-
1
-
-
0030911520
-
Introduction to the EUR-ASSESS report
-
Banta D (1997) Introduction to the EUR-ASSESS Report. Internat J Techn Assess Health Care 13(2): 133-143
-
(1997)
Internat J Techn Assess Health Care
, vol.13
, Issue.2
, pp. 133-143
-
-
Banta, D.1
-
2
-
-
0004851872
-
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
-
Fracture Intervention Trial Research Group
-
Black DM, Cummings SR, Karpf DB, et al (1996) Randomised Trial of Effect of Alendronate on Risk of Fracture in Women with existing Vertebral Fractures. Fracture Intervention Trial Research Group. Lancet 348(9041): 1535-1541
-
(1996)
Lancet
, vol.348
, Issue.9041
, pp. 1535-1541
-
-
Black, D.M.1
Cummings, S.R.2
Karpf, D.B.3
-
3
-
-
0030010992
-
Diphosphonates: And alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate
-
Buffo L, Rossini M, Buoncristiano A, et al (1996) [Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] Minerva-Ginecol 48(6): 263-72
-
(1996)
Minerva-ginecol
, vol.48
, Issue.6
, pp. 263-272
-
-
Buffo, L.1
Rossini, M.2
Buoncristiano, A.3
-
4
-
-
0029116697
-
Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling
-
Chesnut CH 3rd, McClung MR, Ensrud KE, et al (1995) Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. Am J Med. 99(2): 144-52
-
(1995)
Am J Med.
, vol.99
, Issue.2
, pp. 144-152
-
-
Chesnut C.H. III1
McClung, M.R.2
Ensrud, K.E.3
-
5
-
-
0030843969
-
Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108 411 women without breast cancer
-
Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast Cancer and Hormone Replacement Therapy: Collaborative Reanalysis of data from 51 epidemiological studies of 52705 Women with breast Cancer and 108 411 women without breast cancer. Lancet 350: 1047-1059
-
(1997)
Lancet
, vol.350
, pp. 1047-1059
-
-
-
6
-
-
0028963682
-
Risk factors for hip fracture in white women
-
Cummings SR, Nevitt MC, Browner WS, et al (1995) Risk factors for hip fracture in white women. N Engl J Med 332(12): 767-773
-
(1995)
N Engl J Med
, vol.332
, Issue.12
, pp. 767-773
-
-
Cummings, S.R.1
Nevitt, M.C.2
Browner, W.S.3
-
7
-
-
0032583492
-
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures
-
Cummings SR, Black DM, Thompson DE, et al (1998) Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures. JAMA 280(24): 2077-2082
-
(1998)
JAMA
, vol.280
, Issue.24
, pp. 2077-2082
-
-
Cummings, S.R.1
Black, D.M.2
Thompson, D.E.3
-
9
-
-
0031056019
-
Perimenopausal bone density screening: Will it help prevent osteoporosis
-
Garton MJ, Cooper C, Reid C (1997) Perimenopausal bone density screening: will it help prevent osteoporosis. Maturitas 26(1): 35-43
-
(1997)
Maturitas
, vol.26
, Issue.1
, pp. 35-43
-
-
Garton, M.J.1
Cooper, C.2
Reid, C.3
-
11
-
-
0043051375
-
Bone mineral density testing: Does the evidence support its use in well women?
-
The University of Vancouver, B.C., Canada
-
Green CJ, Bassett K, Foersten V, Kazanijan A (1997) Bone mineral density testing: Does the evidence support its use in well women? British Columbia Office of Technology Assessment; Centre for Health Services & Policy Research. The University of Vancouver, B.C., Canada
-
(1997)
British Columbia Office of Technology Assessment; Centre for Health Services & Policy Research
-
-
Green, C.J.1
Bassett, K.2
Foersten, V.3
Kazanijan, A.4
-
12
-
-
0030610461
-
Postmenopausal hormone therapy and mortality
-
Grodstein F, Stampfer MJ, Colditz GA, et al (1997) Postmenopausal hormone therapy and mortality. N Engl J Med 336(25): 1769-1775
-
(1997)
N Engl J Med
, vol.336
, Issue.25
, pp. 1769-1775
-
-
Grodstein, F.1
Stampfer, M.J.2
Colditz, G.A.3
-
13
-
-
0031862370
-
The effectiveness of bone density measurement and associated treatments for prevention of fractures: An International Collaborative Review
-
Hailey D, Sampietro-Colom L, Marshall D, et al (1998) The Effectiveness of Bone Density Measurement and Associated Treatments for Prevention of Fractures: An International Collaborative Review. Internat J Techn Assess Health Care 14(2): 237-255
-
(1998)
Internat J Techn Assess Health Care
, vol.14
, Issue.2
, pp. 237-255
-
-
Hailey, D.1
Sampietro-Colom, L.2
Marshall, D.3
-
14
-
-
0032547326
-
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
-
Hulley S, Grady D, Bush T, Furberg C, Herrington D (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group [see comments]. JAMA: 280(7): 605-13
-
(1998)
JAMA
, vol.280
, Issue.7
, pp. 605-613
-
-
Hulley, S.1
Grady, D.2
Bush, T.3
Furberg, C.4
Herrington, D.5
-
15
-
-
25044440444
-
Memorandum zur evaluierung diagnostischer maßnahmen. Im auftrag der arbeitsgruppe "methoden der prognose- und entscheidungsfindung" in der deutschen gesellschaft für medizinische dokumentation, informatik und statistik e.V. (GMDS)
-
Köbberling J, Trampisch HJ, Windeler J (1989) Memorandum zur Evaluierung diagnostischer Maßnahmen. Im Auftrag der Arbeitsgruppe "Methoden der Prognose- und Entscheidungsfindung" in der Deutschen Gesellschaft für Medizinische Dokumentation, Informatik und Statistik e.V. (GMDS). Nucl Med 28: 255-60
-
(1989)
Nucl Med
, vol.28
, pp. 255-260
-
-
Köbberling, J.1
Trampisch, H.J.2
Windeler, J.3
-
16
-
-
0028851590
-
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
-
Liberman UA, Weiss SR, Bröll J, et al (1995) Effect of oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis. N Engl J Med 333: 1437-43
-
(1995)
N Engl J Med
, vol.333
, pp. 1437-1443
-
-
Liberman, U.A.1
Weiss, S.R.2
Bröll, J.3
-
17
-
-
23844454398
-
Die rolle der osteodensitometrie im rahmen der primär-, sekundär und tertiärprävention/therapie der osteoporose
-
Baden-Baden: Nomos Verlagsgesellschaft
-
Lühmann D, Kohlmann T, Lange S, Raspe H (2000) Die Rolle der Osteodensitometrie im Rahmen der Primär-, Sekundär und Tertiärprävention/Therapie der Osteoporose. Schriftenreihe des DIMDI im Auftrag des Bundesministeriums für Gesundheit. Band 13. Baden-Baden: Nomos Verlagsgesellschaft
-
(2000)
Schriftenreihe des DIMDI Im Auftrag des Bundesministeriums für Gesundheit
, vol.13
-
-
Lühmann, D.1
Kohlmann, T.2
Lange, S.3
Raspe, H.4
-
18
-
-
0029986509
-
Meta-analysis of how well measures of bone mineral density predict occurence of osteoporotic fractures
-
Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurence of osteoporotic fractures. BMJ 312: 1254-1259
-
(1996)
BMJ
, vol.312
, pp. 1254-1259
-
-
Marshall, D.1
Johnell, O.2
Wedel, H.3
-
19
-
-
0030931725
-
Recommendations for the application of bone density measurement. What can you believe?
-
Marshall DA, Sheldon TA, Jonsson E (1997) Recommendations for the application of bone density measurement. What can you believe? Internat J Techn Assess Health Care 13(3): 411-419
-
(1997)
Internat J Techn Assess Health Care
, vol.13
, Issue.3
, pp. 411-419
-
-
Marshall, D.A.1
Sheldon, T.A.2
Jonsson, E.3
-
20
-
-
0025765521
-
Pre-existing fractures and bone mass predict vertebral fracture incidence in women
-
Ross PD, Davis JW, Epstien RS, Wasnich R (1991) Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women. Ann Intern Med 114(11): 919-923
-
(1991)
Ann Intern Med
, vol.114
, Issue.11
, pp. 919-923
-
-
Ross, P.D.1
Davis, J.W.2
Epstien, R.S.3
Wasnich, R.4
-
21
-
-
0028119643
-
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis
-
Rossini M, Gatti D, Zamberlan N, et al (1994) Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. J Bone Min Res 9(11): 1833-1837
-
(1994)
J Bone Min Res
, vol.9
, Issue.11
, pp. 1833-1837
-
-
Rossini, M.1
Gatti, D.2
Zamberlan, N.3
-
23
-
-
0031000660
-
Bone density measurement - A systematic review
-
SBU (1997) Bone Density Measurement - A systematic review. J Inter Med 241 (Suppl. 739): 1-60
-
(1997)
J Inter Med
, vol.241
, Issue.739 SUPPL.
, pp. 1-60
-
-
-
24
-
-
0025366467
-
Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate of women with postmenopausal osteoporosis
-
Storm T, Thamsborg G, Steiniche T, Genant HK, Sörensen OH (1990) Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate of Women with Postmenopausal Osteoporosis. N Engl J Med 322: 1265-71
-
(1990)
N Engl J Med
, vol.322
, pp. 1265-1271
-
-
Storm, T.1
Thamsborg, G.2
Steiniche, T.3
Genant, H.K.4
Sörensen, O.H.5
-
26
-
-
0025334778
-
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
-
Watts NB, Harris ST, Genant HK, et al (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323: 73-9
-
(1990)
N Engl J Med
, vol.323
, pp. 73-79
-
-
Watts, N.B.1
Harris, S.T.2
Genant, H.K.3
-
27
-
-
0029960173
-
Developing evidence-based clinical practice guidelines: Lessons learnt by the U.S. Preventive Services Task Force
-
Woolfe SH, DiGuiseppi CG, Atkins D, Kamerow DB (1996) Developing Evidence-Based Clinical Practice Guidelines: Lessons learnt by the U.S. Preventive Services Task Force. Ann Rev Publ Health 17:511-38
-
(1996)
Ann Rev Publ Health
, vol.17
, pp. 511-538
-
-
Woolfe, S.H.1
DiGuiseppi, C.G.2
Atkins, D.3
Kamerow, D.B.4
|